155 related articles for article (PubMed ID: 18186220)
21. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
[TBL] [Abstract][Full Text] [Related]
22. Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis.
Crayne CB; Gerhold K; Cron RQ
J Clin Rheumatol; 2013 Apr; 19(3):129-31. PubMed ID: 23519173
[TBL] [Abstract][Full Text] [Related]
23. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
24. Acute, non-obstructive, sterile cholecystitis associated with etanercept and infliximab for the treatment of juvenile polyarticular rheumatoid arthritis.
Foeldvari I; Krüger E; Schneider T
Ann Rheum Dis; 2003 Sep; 62(9):908-9. PubMed ID: 12922972
[No Abstract] [Full Text] [Related]
25. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020
[TBL] [Abstract][Full Text] [Related]
26. Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.
Sari I; Binicier O; Birlik M; Akar S; Yilmaz E; Kargi A; Onen F; Akkoc N
Rheumatol Int; 2009 Mar; 29(5):591-3. PubMed ID: 18810448
[TBL] [Abstract][Full Text] [Related]
27. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
Mor A; Bingham CO; Barisoni L; Lydon E; Belmont HM
J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
Otten MH; Prince FH; Anink J; Ten Cate R; Hoppenreijs EP; Armbrust W; Koopman-Keemink Y; van Pelt PA; Kamphuis S; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
Ann Rheum Dis; 2013 May; 72(5):721-7. PubMed ID: 22730374
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
Giannini EH; Ilowite NT; Lovell DJ; Wallace CA; Rabinovich CE; Reiff A; Higgins G; Gottlieb B; Chon Y; Zhang N; Baumgartner SW
Arthritis Rheum; 2010 Nov; 62(11):3259-64. PubMed ID: 20669280
[TBL] [Abstract][Full Text] [Related]
31. Cerebral demyelination in association with TNF-inhibition therapy in a 5-year-old girl with aseptic meningitis as the first symptom of Still's disease.
Kunzmann S; Warmuth-Metz M; Girschick HJ
Scand J Rheumatol; 2005; 34(1):76-8. PubMed ID: 15903034
[No Abstract] [Full Text] [Related]
32. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
[No Abstract] [Full Text] [Related]
33. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.
Berard RA; Laxer RM
Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
Foeldvari I; Nielsen S; Kümmerle-Deschner J; Espada G; Horneff G; Bica B; Olivieri AN; Wierk A; Saurenmann RK
J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
[TBL] [Abstract][Full Text] [Related]
35. Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.
Lin KC; Liang CD; Yang KD; Yu HR; Kuo HC
Rheumatol Int; 2012 May; 32(5):1383-5. PubMed ID: 20349235
[TBL] [Abstract][Full Text] [Related]
36. Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis.
Holl-Wieden A; Beer M; Marx A; Bonfig R; Tappe D; Girschick HJ
Rheumatol Int; 2008 Jun; 28(8):819-22. PubMed ID: 18193232
[TBL] [Abstract][Full Text] [Related]
37. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age.
Bracaglia C; Buonuomo PS; Tozzi AE; Pardeo M; Nicolai R; Campana A; Insalaco A; Cortis E; DE Benedetti F
J Rheumatol; 2012 Jun; 39(6):1287-90. PubMed ID: 22589254
[TBL] [Abstract][Full Text] [Related]
39. Onset of multiple sclerosis associated with anti-TNF therapy.
Sicotte NL; Voskuhl RR
Neurology; 2001 Nov; 57(10):1885-8. PubMed ID: 11723281
[TBL] [Abstract][Full Text] [Related]
40. [Unilateral uveitis with HHV6-positive polymerase chain reaction in aqueous humor for an etanercept-treated woman: a case report].
Glâtre F; Rousseau E; Bacin F
J Fr Ophtalmol; 2010 Oct; 33(8):561-3. PubMed ID: 20727619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
